Grenoble -- Xenocs, a global leader in Small Angle X-ray Scattering (SAXS) technology, and Malvern Panalytical, renowned for its expertise in materials characterization, are pleased to announce a collaboration aimed at transforming pharmaceutical analytics. This joint marketing initiative will deliver a unique, comprehensive solution to the pharmaceutical sector’s analytical challenges. Through various initiatives, such as [...]

New York, NY and Strasbourg, France – Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today that it has expanded internationally via a partnership with FAMECO Group ApS (“FAMECO” or the “Company”). Terms of the transaction were not disclosed. Founded in 2000 and headquartered in Strasbourg, France, FAMECO is an international [...]

State-of-the-art innovation lab pushes the limits of advanced semiconductor applications. Dresden, Germany |  ZEISS Research Microscopy Solutions -- ZEISS has announced it recently opened the ZEISS Microscopy semiconductor applications lab in Dresden, a state-of-the-art facility dedicated to addressing physical analysis challenges and pushing the limits of nanoscale analysis with the ZEISS Crossbeam focused ion beam-scanning [...]

Combining Dynamic Biosensors’ Innovative Technologies with Bruker’s High-Performance SPR Portfolio to Establish a Leading Biosensors Business MUNICH -- Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Dynamic Biosensors GmbH , a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker’s biophysical portfolio for the analysis of molecular [...]

Dr Gordon McInroy appointed as COO, Dr Tobias Ost as SVP Product Development, and Charu Maini as SVP of People Cambridge, UK: Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop eProtein Discovery™ system, today announced key leadership changes, including Dr Gordon McInroy’s promotion to the role of Chief Operating Officer, Dr Tobias Ost [...]

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization. RADNOR, Pa. -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has completed the acquisition of Chemaxon. Chemaxon develops leading scientific informatics software products used by the life [...]

BILLERICA, Mass. -- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the appointment of Ivana Magovčević-Liebisch, Ph.D., J.D. to its Board of Directors. Dr. Magovčević-Liebisch brings more than 25 years of biopharmaceutical industry experience, including founding Vigil Neuroscience, Inc. four years ago, where she serves [...]

SAN FRANCISCO -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced that it has expanded its collaboration with AmplifyBio, a rapidly growing contract development and manufacturing organization, through the installation of a new AVATAR™ Foundry system as part of Xcellbio’s beta access program. The new instrument will [...]

LANSING, Mich. — Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has appointed Thierry Bernard as a director to its Board, effective November 1, 2024. “We are pleased to welcome Thierry Bernard to the Neogen Board of Directors and look forward to his guidance as the company continues [...]

Irvine, CA — Zymo Research Corporation and BluMaiden Biosciences are joining forces to offer end-to-end clinical trial analytics and reporting services based on the human microbiome. This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan. The partnership combines Zymo Research's expertise [...]